Hicks RJ - Search Results

1

PET/CT variants and pitfalls in malignant melanoma.

Aide N, Iravani A, Prigent K, Kottler D, Alipour R, Hicks RJ. Aide N, et al. Among authors: hicks rj. Cancer Imaging. 2022 Jan 4;22(1):3. doi: 10.1186/s40644-021-00440-4. Cancer Imaging. 2022. PMID: 34983677 Free PMC article. Review.

2

Positron emission tomography (PET): experience with a large-field-of-view three-dimensional PET scanner.

Hicks RJ, Binns DS, Fawcett ME, Ware RE, Kalff V, McKenzie AF, Zalcberg JP, Peters LJ. Hicks RJ, et al. Med J Aust. 1999 Nov 15;171(10):529-32. doi: 10.5694/j.1326-5377.1999.tb123787.x. Med J Aust. 1999. PMID: 10816703

3

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

MacManus MP, Hicks RJ, Matthews JP, Hogg A, McKenzie AF, Wirth A, Ware RE, Ball DL. MacManus MP, et al. Among authors: hicks rj. Int J Radiat Oncol Biol Phys. 2001 Jun 1;50(2):287-93. doi: 10.1016/s0360-3016(01)01477-8. Int J Radiat Oncol Biol Phys. 2001. PMID: 11380213 Clinical Trial.

4

Pattern of uptake and excretion of (18)F-FDG in the lactating breast.

Hicks RJ, Binns D, Stabin MG. Hicks RJ, et al. J Nucl Med. 2001 Aug;42(8):1238-42. J Nucl Med. 2001. PMID: 11483686 Free article. Clinical Trial.

5

A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment.

Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. Narayan K, et al. Among authors: hicks rj. Int J Gynecol Cancer. 2001 Jul-Aug;11(4):263-71. doi: 10.1046/j.1525-1438.2001.011004263.x. Int J Gynecol Cancer. 2001. PMID: 11520363

6

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.

Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Matthews JP, Salminen E, Khaw P, Wirth A, Rischin D, McKenzie A. Mac Manus MP, et al. Among authors: hicks rj. Cancer. 2001 Aug 15;92(4):886-95. doi: 10.1002/1097-0142(20010815)92:4<886::aid-cncr1397>3.0.co;2-v. Cancer. 2001. PMID: 11550162

7

(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.

Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1596-604. J Nucl Med. 2001. PMID: 11696627 Free article. Clinical Trial.

8

The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification.

Hicks RJ, Kalff V, MacManus MP, Ware RE, McKenzie AF, Matthews JP, Ball DL. Hicks RJ, et al. J Nucl Med. 2001 Nov;42(11):1605-13. J Nucl Med. 2001. PMID: 11696628 Free article. Clinical Trial.

9

Imaging with F-18 FDG PET is superior to Tl-201 SPECT in the staging of non-small cell lung cancer for radical radiation therapy.

MacManus MP, Hicks RJ, Ball DL, Ciavarella F, Binns D, Hogg A, Kalff V, Ware R, Wirth A, Salminen E, McKenzie A. MacManus MP, et al. Among authors: hicks rj. Australas Radiol. 2001 Nov;45(4):483-90. doi: 10.1046/j.1440-1673.2001.00960.x. Australas Radiol. 2001. PMID: 11903182

10

Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.

Kalff V, Hicks RJ, Ware RE, Greer B, Binns DS, Hogg A. Kalff V, et al. Among authors: hicks rj. Eur J Nucl Med Mol Imaging. 2002 Apr;29(4):506-15. doi: 10.1007/s00259-001-0735-8. Epub 2002 Feb 15. Eur J Nucl Med Mol Imaging. 2002. PMID: 11914889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

599 results

Search Page

Filters